LobbyingRwe Alliance lobbying by quarter
Rwe Alliance's latest lobbying report covers Q2 2026, at $30K. The four quarters Q4 2025–Q3 2026 total $30K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medical/Disease Research/Clinical Labs.
Rwe Alliance
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $30K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $30K | 1 |
| Q1 2023 | $0 | 1 |
| Q2 2023 | $30K | 1 |
| Q3 2023 | $100K | 1 |
| Q4 2023 | $30K | 1 |
| Q1 2024 | $60K | 1 |
| Q2 2024 | $70K | 1 |
| Q3 2024 | $30K | 1 |
| Q4 2024 | $20K | 1 |
| Q1 2025 | $30K | 1 |
| Q2 2025 | $10K | 1 |
| Q3 2025 | $80K | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $30K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$188.3K · 13 reports
- Medical research and clinical labs$188.3K · 13 reports
- Science and technology$143.3K · 9 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- SENATE6 reports
- HOUSE OF REPRESENTATIVES5 reports
- Food & Drug Administration (FDA)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Covington & Burling | $520K | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/17for Q2 | Covington & Burling | $30K |
| 04/08for Q1 | Covington & Burling | Under $5,000 |
| 01/15for Q4 2025 | Covington & Burling | Under $5,000 |
| 25/10/16for Q3 2025 | Covington & Burling | $80K |
| 25/07/21for Q2 2025 | Covington & Burling | $10K |
| 25/04/17for Q1 2025 | Covington & Burling | $30K |
| 25/01/15for Q4 2024 | Covington & Burling | $20K |
| 24/10/17for Q3 2024 | Covington & Burling | $30K |
| 24/07/17for Q2 2024 | Covington & Burling | $70K |
| 24/04/15for Q1 2024 | Covington & Burling | $60K |
| 24/01/19for Q4 2023 | Covington & Burling | $30K |
| 23/10/18for Q3 2023 | Covington & Burling | $100K |
| 23/07/20for Q2 2023 | Covington & Burling | $30K |
| 23/04/20for Q1 2023 | Covington & Burling | Under $5,000 |
| 23/01/20for Q4 2022 | Covington & Burling | $30K |